XML 92 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (7,955,663) $ (3,813,800)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Depreciation 11,726 21,162
Amortization 38,502 29,157
Amortization of Debt Discount 669,148
Amortization of ROU Asset 13,517 50,053
Amortization of Note Issuance Costs 67,728
Amortization of Capitalized Share-Based Payments 3,575,881 994,643
Share-Based Compensation to Vendors for Services 212,605
Share-Based Compensation under Equity Incentive Plan 32,767 528,926
Deemed Capital Contribution for Related Party Compensation Expense (Note 10)   163,228
Loss on Debt Extinguishment 1,231,480
Change in Fair Value of Derivative Liabilities (1,665,966) 37,278
Derivative Expense 399,725
Change in Fair Value of Promissory Note (5,379,269)
Write-offs of Capitalized Patents 108,424
Inventory Reserve (160,338)
Changes in Operating Assets and Liabilities:    
Accounts Receivable (255,416) (185,367)
Prepaid and Other Assets (39,423) (522,370)
Inventory 23,405 212,747
Accounts Payable and Accrued Liabilities 501,412 (214,734)
Accrued Interest, net (23,604) 1,265,361
Reduction of Lease Liability (13,650) (50,273)
Deferred Compensation (100,000)
Net Cash Used in Operating Activities (5,648,088) (4,542,910)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalization of Patents (51,967) (39,982)
Purchases of Fixed Assets (103,773) (57,623)
Acquisition of Intangibles (25,374) (18,283)
Purchase of Short-Term Investments (1,708,000)
Net Cash Used in Investing Activities (1,889,114) (115,888)
CASH FLOWS FROM FINANCING ACTIVITIES    
Net Proceeds from January 2024 Offering 1,898,296
Proceeds from IPO and Over-Allotment, net of underwriting discounts, commissions, and deferred offering costs paid in 2023 of $1,198,111 6,303,905
Proceeds from ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 1,729,810
Proceeds from Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600 3,414,502
Proceeds from Exercise of Warrants 1,131,771
Proceeds from Exercise of Pre-Funded Warrants 10,963
Proceeds from Notes Payable 650,000
Repayment of Notes Payable (1,611,111)
Proceeds from Advances - Related Party 250,000
Repayment of Related Party Advances (250,000)
Net Cash Provided by Financing Activities 7,053,571 6,474,565
Effect of Exchange Rate Changes on Cash 499 61,853
Change in Cash and Cash Equivalents (483,132) 1,877,620
Cash and Cash Equivalents—Beginning of Period 2,142,485 264,865
Cash and Cash Equivalents—End of Period 1,659,353 2,142,485
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid During the Year for Interest 8,772 179,117
Cash paid During the Year for Income Taxes 2,000 1,000
NONCASH INVESTING/FINANCING ACTIVITIES    
Conversion of Debt into Common Stock 7,989,598
Conversion of Debt into Series A Preferred Stock 10,128,500
Conversion of Series A Preferred Stock into Common Stock 290,601 270,460
Capitalized Share-Based Payments to Vendors 26,325 4,916,555
Fair Value of Warrants Issued to Underwriters 71,364 301,416
Reclassification of Liability-classified Warrants to Equity-classified 838,748
Additions to ROU Assets for Lease Renewal 50,922
Additions to Lease Liabilities for Lease Renewal 50,570
Debt Discount Recorded in Connection with Derivative Liabilities 650,000
Stock Issued for Payment of Deferred Compensation 520,000
Stock Issued for Acquisition of Intangibles $ 33,895